← 返回

细胞外基质相关基因 CILP、MFAP4 和 MMRN1 下调揭示其与结直肠癌免疫浸润及临床结局的关联:生物信息学与实验验证

英文原题:Downregulated extracellular matrix-associated CILP, MFAP4, and MMRN1 genes reveal links to immune infiltration and clinical outcomes in colorectal cancer: bioinformatics and experimental validation.

查看英文原题

Downregulated extracellular matrix-associated CILP, MFAP4, and MMRN1 genes reveal links to immune infiltration and clinical outcomes in colorectal cancer: bioinformatics and experimental validation.

PubMed 2026/04/25(内容时间) Cancer Treat Res Commun Q2 · IF 3.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

这些发现表明,CILP、MFAP4 和 MMRN1 在 CRC 中作为潜在的肿瘤抑制因子和免疫调节因子发挥作用。它们在肿瘤组织中的显著下调,以及与免疫浸润和临床特征的关联,提示它们可能在 CRC 发病机制中发挥作用,并使其成为潜在的治疗靶点。

研究思路结论见上方概要

结直肠癌(CRC)是癌症死亡的主要原因之一。细胞外基质(ECM)在肿瘤进展中起关键作用,其相关基因可能作为预后生物标志物。本研究探讨了三个ECM相关基因CILP、MFAP4和MMRN1,以评估它们在CRC发生中的表达及临床意义。

对来自TCGA-COAD的RNA-seq数据和微阵列数据集(GSE23878、GSE89076)进行分析,以识别差异表达基因(DEGs)。生物信息学分析包括功能富集、蛋白质-蛋白质相互作用(PPI)网络构建和免疫浸润评估。使用RT-qPCR对20对CRC及癌旁非癌组织进行实验验证。评估了基因表达、临床病理特征与总生存期之间的关联。

RNA-seq和microarray分析均显示,与癌旁样本相比,CRC组织中CILP、MFAP4和MMRN1显著下调(p < 0.05)。RT-qPCR证实肿瘤组织中表达水平较低(p < 0.0001)。TIMER数据库的免疫细胞浸润分析显示,目标基因与TIL(肿瘤浸润淋巴细胞)呈正相关,尤其是CD 8 + T细胞和巨噬细胞。此外,MFAP4表达与淋巴结状态显著相关(p < 0.05),而MFAP4和MMRN1均与较小的肿瘤大小相关(p = 0.04)。生存分析显示,基因表达较低的患者预后较差的趋势不显著。

展开英文摘要原文

Colorectal cancer (CRC) is a leading cause of cancer mortality. The extracellular matrix (ECM) plays a critical role in tumor progression, and its associated genes may serve as prognostic biomarkers. This study investigated three ECM-related genes, CILP, MFAP4, and MMRN1, to evaluate their expression and clinical significance in CRC development.

RNA-seq data from TCGA-COAD and microarray datasets (GSE23878, GSE89076) were analyzed to identify differentially expressed genes (DEGs). Bioinformatics analyses included functional enrichment, protein-protein interaction (PPI) network construction, and immune infiltration evaluation. Experimental validation was performed using RT-qPCR on 20 paired CRC and adjacent non-cancerous tissues. Associations between gene expression, clinicopathological features, and overall survival were assessed.

Both RNA-seq and microarray analyses revealed significant downregulation of CILP, MFAP4, and MMRN1 in CRC tissues compared to non-cancerous samples (p < 0.05). RT-qPCR confirmed lower expression levels in tumor tissues (p < 0.0001). TIMER database analysis for immune cell infiltration revealed positive correlations between target genes and tumor-infiltrating lymphocytes, particularly CD 8 + T cells and macrophages. Moreover, MFAP4 expression showed a significant association with lymph node status (p < 0.05), while both MFAP4 and MMRN1 were found to be correlated with smaller tumor size (p = 0.04). Survival analysis showed non-significant trends toward poorer prognosis in patients with lower gene expression.

These findings demonstrated that CILP, MFAP4, and MMRN1 function as potential tumor suppressors and immunomodulators in CRC. Their significant downregulation in tumor tissues, along with associations with immune infiltration and clinical features, suggest a possible role in CRC pathogenesis and make them potential therapeutic targets.

论文信息

作者
Golestannejad E、Kalantary-Charvadeh A、Karimi J、Khodadadi I
第一作者单位
Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran; Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.Iran
通讯作者单位
Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran; Nutrition Health Research Center, Institute of Health Sciences and Technologies, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: khodadadi@umsha.ac.ir.Iran
期刊
Cancer treatment and research communications2026
原文标识
PubMed 42102586 · DOI 10.1016/j.ctarc.2026.101206